Paul Richards
Hematology & Oncology · Salem, VANPI 1053387266
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,062 of the $1,232 with a category attached, or 86.2%. It is spread thinly across 21 manufacturers, the largest accounting for just 15.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $616 and has fallen 89.5% since, to $65 in 2023. That places this record below the midpoint for hematology & oncology clinicians in VA, where the typical reported total is $1,232.
Across 31 payments — averaging $39.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$185
- Jazz Pharmaceuticals Inc.$120
- Regeneron Healthcare Solutions, Inc.$119
- Pharmacyclics LLC, An Abbvie Company$118
- GE HealthCare$104
- E.r. Squibb & Sons, L.L.C.$94
- plus $493 from 15 others
Across 626 payments — averaging $2746.77 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Seagen Inc.$904K
- Eli Lilly$351K
- Pfizer$129K
- Novartis$104K
- Eisai Inc.$89K
- Sanofi US Services Inc.$57K
- plus $86K from 6 others
What the payments were for
- Food & beverage$1,06286%
- Education$17014%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 2 | $185 |
| Jazz Pharmaceuticals Inc. | 2 | $120 |
| Regeneron Healthcare Solutions, Inc. | 2 | $119 |
| Pharmacyclics LLC, An Abbvie Company | 1 | $118 |
| GE HealthCare | 1 | $104 |
| E.r. Squibb & Sons, L.L.C. | 1 | $94 |
| Tactile Systems Technology Inc | 3 | $90 |
| Lilly USA, LLC | 1 | $84 |
| Johnson & Johnson | 1 | $65 |
| Adaptive Biotechnologies Corporation | 2 | $46 |
| Bristol Myers Squibb | 2 | $37 |
| Pfizer | 4 | $25 |
| Puma Biotechnology, Inc. | 1 | $21 |
| Incyte Corporation | 1 | $20 |
| Astellas Pharma US Inc | 1 | $18 |
| Daiichi Sankyo Inc. | 1 | $18 |
| Seagen Inc. | 1 | $17 |
| AstraZeneca | 1 | $16 |
| Boehringer Ingelheim | 1 | $13 |
| Myriad Genetic Laboratories, Inc. | 1 | $12 |
| Gilead | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,232 in reported general payments places this provider in the 50th percentile of 293 hematology & oncology providers in Virginia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Letrozole | 17 | $436 |
| Famotidine | 11 | $103 |
Paid to pharmacies, not to this prescriber.
Other hematology & oncology in Salem
- Vandana KarriSalem$15K
- Mark CurrieSalem$12K
- Ruby KochharHampton$236K
- Victor YazbeckRichmond$190K
- David ChangNewport News$141K
- William ErshlerFairfax$139K
- Yue ZhangVirginia Beach$105K
- Jerome GoldschmidtChristiansburg$105K
- Attique SamdaniRichmond$104K
- Gary SimmonsNorfolk$82K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.